| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 |
Kodiak Sciences Inc
KOD
|
BUY |
$120.00
Est. +33%
|
$89.92 | $104.00 |
Pending
|
$91.35
+1.6%
|
| Sep 17, 2026 |
AMGEN Inc.
AMGN
|
BUY |
$430.00
Est. +14%
|
$378.42 | $441.76 |
Precision Hit (±3%)
|
$424.94
+12.3%
|
| Aug 20, 2026 |
Moderna Inc
MRNA
|
SELL |
$150.00
Est. +14%
|
$174.38 | $130.00 (Low) |
Target Met
|
$226.89
-30.1%
|
| Jul 23, 2026 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$90.00
Est. +46%
|
$61.84 | $72.64 |
Pending
|
$52.48
-15.1%
|
| Jun 09, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$175.00
Est. +18%
|
$148.45 | $224.31 |
Target Met
|
$182.15
+22.7%
|
| May 27, 2026 |
Pfizer Inc.
PFE
|
BUY |
$27.00
Est. +2%
|
$26.35 | $29.88 |
Target Met
|
$29.44
+11.7%
|
| Apr 21, 2026 |
First Tracks Biotherapeutics Inc
TRAX
|
BUY |
$45.00
Est. +142%
|
$18.60 | $40.50 |
Pending
|
$36.28
+95.1%
|
| Mar 06, 2026 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$70.00
Est. +17%
|
$59.79 | $68.24 |
Precision Hit (±3%)
|
$58.83
-1.6%
|
| Feb 24, 2026 |
Arcellx Inc
ACLX
|
BUY |
$115.00
Est. +1%
|
$113.75 | $115.13 |
Bullseye Hit (±1%)
|
$115.07
+1.2%
|
| Jan 08, 2026 |
Ventyx Biosciences Inc
VTYX
|
BUY |
$14.00
Est. +2%
|
$13.73 | $14.07 |
Bullseye Hit (±1%)
|
$14.00
+2.0%
|
| Jan 07, 2026 |
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
|
BUY |
$10.00
Est. +18%
|
$8.49 | $9.10 |
Pending
|
$4.48
-47.2%
|
| Jan 07, 2026 |
Immunocore Holdings plc - ADR
IMCR
|
BUY |
$55.00
Est. +67%
|
$32.85 | $37.95 |
Pending
|
$29.84
-9.2%
|
| Jan 07, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$145.00
Est. +19%
|
$121.36 | $160.49 |
Target Met
|
$153.07
+26.1%
|
| Jan 07, 2026 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$60.00
Est. +109%
|
$28.70 | $72.64 |
Target Met
|
$52.48
+82.9%
|
| Jan 07, 2026 |
Oruka Therapeutics, Inc.
ORKA
|
BUY |
$50.00
Est. +88%
|
$26.62 | $112.95 |
Target Met
|
$74.48
+179.8%
|
| Jan 07, 2026 |
Schrodinger Inc
SDGR
|
SELL |
$18.00
Est. +4%
|
$18.79 | $10.95 (Low) |
Target Met
|
$23.12
-23.0%
|
| Jan 07, 2026 |
Olema Pharmaceuticals Inc
OLMA
|
BUY |
$45.00
Est. +80%
|
$25.04 | $29.50 |
Pending
|
$7.11
-71.6%
|
| Jan 07, 2026 |
AnaptysBio Inc
ANAB
|
BUY |
$70.00
Est. +59%
|
$43.91 | $72.27 |
Target Met
|
$49.24
+12.1%
|
| Jan 07, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$60.00
Est. +45%
|
$41.31 | $61.75 |
Precision Hit (±3%)
|
$40.24
-2.6%
|
| Jan 07, 2026 |
Cogent Biosciences Inc
COGT
|
BUY |
$60.00
Est. +73%
|
$34.78 | $43.39 |
Pending
|
$30.01
-13.7%
|
| Jan 07, 2026 |
Kodiak Sciences Inc
KOD
|
BUY |
$50.00
Est. +100%
|
$25.05 | $104.00 |
Target Met
|
$91.35
+264.7%
|
| Jan 07, 2026 |
Beam Therapeutics Inc
BEAM
|
SELL |
$28.00
Est. +1%
|
$28.34 | $21.63 (Low) |
Target Met
|
$24.19
+14.6%
|
| Jan 07, 2026 |
Denali Therapeutics Inc
DNLI
|
BUY |
$25.00
Est. +45%
|
$17.21 | $27.30 |
Target Met
|
$18.04
+4.8%
|
| Jan 07, 2026 |
Arcellx Inc
ACLX
|
BUY |
$100.00
Est. +61%
|
$62.06 | $115.13 |
Target Met
|
$115.07
+85.4%
|
| Jan 07, 2026 |
SAB Biotherapeutics Inc
SABS
|
BUY |
$7.00
Est. +93%
|
$3.62 | $5.15 |
Pending
|
$2.60
-28.2%
|
| Jan 07, 2026 |
Inventiva - ADR
IVA
|
BUY |
$12.00
Est. +164%
|
$4.54 | $7.29 |
Pending
|
$2.98
-34.4%
|
| Jan 07, 2026 |
Aligos Therapeutics Inc
ALGS
|
BUY |
$20.00
Est. +128%
|
$8.76 | $10.49 |
Pending
|
$4.84
-44.7%
|
| Jan 06, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,250.00
Est. +17%
|
$1,064.04 | $1,275.88 |
Precision Hit (±3%)
|
$1,240.34
+16.6%
|
| Jan 06, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$535.00
Est. +14%
|
$468.38 | $560.25 |
Target Met
|
$501.95
+7.2%
|